ABLA
OGN icon

Alan B. Lancz & Associates’s Organon & Co OGN Stock Holding History

Alan B. Lancz & Associates’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,224
Closed -$170K – 171
2023
Q1 		$170K Buy
7,224
+10
+0.1% +$269 0.18% 139
2022
Q4 		$231K Hold
7,214
– – 0.23% 115
2022
Q3 		$169K Hold
7,214
– – 0.2% 126
2022
Q2 		$229K Sell
7,214
-250
-3% -$8.76K 0.23% 117
2022
Q1 		$261K Hold
7,464
– – 0.23% 115
2021
Q4 		$227K Buy
+7,464
New +$243K 0.2% 130

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Alan B. Lancz & Associates's OGN Position: Q2 2023 in Review

Alan B. Lancz & Associates sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 7,224 shares — an estimated $170K sold.

Alan B. Lancz & Associates first reported a position in OGN in Q4 2021 and held it in 6 quarters. The position peaked at $261K in Q1 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Alan B. Lancz & Associates reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Alan B. Lancz & Associates sold 7,224 Organon & Co shares in Q2 2023, an estimated $170K.
  • Alan B. Lancz & Associates first reported a position in Organon & Co in Q4 2021 and held it in 6 quarters.
  • Alan B. Lancz & Associates's Organon & Co position peaked at $261K in Q1 2022.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Alan B. Lancz & Associates's 13F filing for Q2 2023, filed 9 Aug 2023.